Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Standing systolic blood pressure"'
Autor:
David M. Sletten, Tonette L. Gehrking, Phillip A. Low, Jade A. Gehrking, Paola Sandroni, Jeffrey R. Basford, Juan J. Figueroa, Wolfgang Singer
Publikováno v:
Archives of Physical Medicine and Rehabilitation. 96:505-510
To assess the effects of patient-controlled abdominal compression on postural changes in systolic blood pressure (SBP) associated with orthostatic hypotension (OH). Secondary variables included subject assessments of their preferences and the ease-of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd36233c7926493cd318de60ba4dc560
https://doi.org/10.1016/j.apmr.2014.10.012
https://doi.org/10.1016/j.apmr.2014.10.012
Publikováno v:
Drugs. 40:26-29
Isradipine, a new calcium antagonist, was administered to 51 Pakistani patients with hypertension (36 women, 15 men; mean age 47 years) over an 8-week period. Mean sitting systolic, and sitting and standing diastolic blood pressure was significantly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a7c4b7e82c6f4f2f322c4cbd4d5c2ee
https://doi.org/10.2165/00003495-199000402-00008
https://doi.org/10.2165/00003495-199000402-00008
The effects of sulindac and indomethacin on the blood pressure response to labetalol were determined in well-controlled predominantly obese hypertensive patients (n = 26). A stabilized dose of labetalol alone was administered on weeks 1 and 3, and ei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25af91731a47039170fddc51ad3f0373
https://europepmc.org/articles/PMC1368369/
https://europepmc.org/articles/PMC1368369/
Publikováno v:
Journal of Cardiovascular Pharmacology. 17:S28-S29
The antihypertensive efficacy and safety of amlodipine (5-10 mg once daily for 10 weeks) was assessed in elderly patients with primary systolic hypertension (average sitting and standing systolic blood pressureor = 160 mm Hg and diastolic blood press
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::233bfa83e5a0e47026459b5301e14881
https://doi.org/10.1097/00005344-199117001-00010
https://doi.org/10.1097/00005344-199117001-00010
Publikováno v:
Anesthesiology. 89:824A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4a53ed9c115a9a06dd222345f37ef89
https://doi.org/10.1097/00000542-199809140-00007
https://doi.org/10.1097/00000542-199809140-00007
Publikováno v:
JAMA: The Journal of the American Medical Association. 278:388
In Reply. —Dr Berlin raises several important questions regarding the size and design of our study. First, the data presented in Figures 2 and 3 of our article were based on intention-to-treat analysis. When the dropouts were excluded, the statisti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22da5b9eebc3f83fb9ee31051a48f3e0
https://doi.org/10.1001/jama.1997.03550050050029
https://doi.org/10.1001/jama.1997.03550050050029
Autor:
J Boberg, T Thulin, Bengt E. Karlberg, Lennart Hansson, Peter Öhman, M Danielson, S Jern, O Andersson, C. Mörlin, Björn Dahlöf
Publikováno v:
British journal of clinical pharmacology. 18(6)
The objective of this placebo controlled double-blind multicentre (six centres) trial was to investigate the safety and efficacy of ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor antagonist with modest intrinsic sympathomimetic activity (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82f5ce0ba3bfc91762f9072977709f32
https://pubmed.ncbi.nlm.nih.gov/6152175
https://pubmed.ncbi.nlm.nih.gov/6152175
The relation between dose, systemic availability, and response to oral debrisoquine was studied in 13 hypertensive patients receiving no other treatment. In 11 who received the same daily dose (40 mg) the fall in mean standing systolic blood pressure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::914ea323b3c5ba7b600e7d03c19a05f9
https://europepmc.org/articles/PMC1604845/
https://europepmc.org/articles/PMC1604845/
Publikováno v:
The American journal of cardiology. 49(2)
The effects of different oral doses of isosorbide dinitrate administered acutely and four times daily during sustained therapy were studied in 12 patients with angina pectoris. After administration of 30, 60 and 120 mg of isosorbide dinitrate, the av
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::974deae8b269b4ea5f31517ef05e5b74
https://pubmed.ncbi.nlm.nih.gov/7058754
https://pubmed.ncbi.nlm.nih.gov/7058754